Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1CERLIPONASE ALFA

02 1ELOSULFASE ALFA

03 1GALSULFASE

04 1LARONIDASE

05 3PEGVALIASE-PQPZ

06 3SAPROPTERIN DIHYDROCHLORIDE

07 3VOSORITIDE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : BRINEURA

2024 ACI Convention
Not Confirmed
arrow

Brand Name : BRINEURA

2024 ACI Convention
Not Confirmed
arrow

BioMarin Pharmaceutical

Dosage Form : INJECTABLE; INJECTION

Proprietary Name : BRINEURA

Dosage Strength : 30MG/ML

Approval Date :

Application Number : 761052

RX/OTC/DISCN :

RLD :

TE Code :

blank

02

Brand Name : VIMIZIM

2024 ACI Convention
Not Confirmed
arrow

Brand Name : VIMIZIM

2024 ACI Convention
Not Confirmed
arrow

BioMarin Pharmaceutical

Dosage Form : INJECTABLE; INJECTION

Proprietary Name : VIMIZIM

Dosage Strength : 5MG/5ML

Approval Date :

Application Number : 125460

RX/OTC/DISCN :

RLD :

TE Code :

blank

03

Brand Name : NAGLAZYME

2024 ACI Convention
Not Confirmed
arrow

Brand Name : NAGLAZYME

2024 ACI Convention
Not Confirmed
arrow

BioMarin Pharmaceutical

Dosage Form : INJECTABLE; INJECTION

Proprietary Name : NAGLAZYME

Dosage Strength : 5MG/5ML

Approval Date :

Application Number : 125117

RX/OTC/DISCN :

RLD :

TE Code :

blank

04

Brand Name : ALDURAZYME

2024 ACI Convention
Not Confirmed
arrow

Brand Name : ALDURAZYME

2024 ACI Convention
Not Confirmed
arrow

BioMarin Pharmaceutical

Dosage Form : VIAL

Proprietary Name : ALDURAZYME

Dosage Strength : 2.9MG/ML

Approval Date :

Application Number : 125058

RX/OTC/DISCN :

RLD :

TE Code :

blank

05

Brand Name : PALYNZIQ

2024 ACI Convention
Not Confirmed
arrow

Brand Name : PALYNZIQ

2024 ACI Convention
Not Confirmed
arrow

BioMarin Pharmaceutical

Dosage Form : INJECTABLE; INJECTION

Proprietary Name : PALYNZIQ

Dosage Strength : 2.5MG/O.5ML

Approval Date :

Application Number : 761079

RX/OTC/DISCN :

RLD :

TE Code :

blank

06

Brand Name : PALYNZIQ

2024 ACI Convention
Not Confirmed
arrow

Brand Name : PALYNZIQ

2024 ACI Convention
Not Confirmed
arrow

BioMarin Pharmaceutical

Dosage Form : INJECTABLE; INJECTION

Proprietary Name : PALYNZIQ

Dosage Strength : 10MG/0.5ML

Approval Date :

Application Number : 761079

RX/OTC/DISCN :

RLD :

TE Code :

blank

07

Brand Name : PALYNZIQ

2024 ACI Convention
Not Confirmed
arrow

Brand Name : PALYNZIQ

2024 ACI Convention
Not Confirmed
arrow

BioMarin Pharmaceutical

Dosage Form : INJECTABLE; INJECTION

Proprietary Name : PALYNZIQ

Dosage Strength : 20MG/ML

Approval Date :

Application Number : 761079

RX/OTC/DISCN :

RLD :

TE Code :

blank

08

Brand Name : KUVAN

2024 ACI Convention
Not Confirmed
arrow

Brand Name : KUVAN

2024 ACI Convention
Not Confirmed
arrow

BioMarin Pharmaceutical

Dosage Form : TABLET; ORAL

Proprietary Name : KUVAN

Dosage Strength : 100MG

Approval Date : 2007-12-13

Application Number : 22181

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

09

Brand Name : KUVAN

2024 ACI Convention
Not Confirmed
arrow

Brand Name : KUVAN

2024 ACI Convention
Not Confirmed
arrow

BioMarin Pharmaceutical

Dosage Form : POWDER; ORAL

Proprietary Name : KUVAN

Dosage Strength : 100MG/PACKET

Approval Date : 2013-12-19

Application Number : 205065

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

10

Brand Name : KUVAN

2024 ACI Convention
Not Confirmed
arrow

Brand Name : KUVAN

2024 ACI Convention
Not Confirmed
arrow

BioMarin Pharmaceutical

Dosage Form : POWDER; ORAL

Proprietary Name : KUVAN

Dosage Strength : 500MG/PACKET

Approval Date : 2015-10-27

Application Number : 205065

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank